Animal Health

New partnerships with CVMA and AMVQ offer tailored insurance to combat rising costs and burnout, a key move in Western Financial Group's national growth plan.

Ottawa's quiet $892K investment in a Vancouver biotech firm is more than a grant; it's a calculated move to secure Canada's food supply from a post-antibiotic crisis.

A new enzyme blend for dogs boasts a 92% success rate in a clinical trial. We analyze the data and what it means for the pet supplement industry's future.

For its 75th anniversary, the iconic rotisserie chain is partnering with pet retailer Mondou, tapping into the booming pet humanization market.

How a sparkling water brand and a grocery chain are humanizing corporate giving by empowering communities to support veterans, one service dog at a time.

Beyond honoring veterinary heroes, Trupanion's record-breaking awards program reveals a savvy strategy to build industry trust and deepen its moat in a booming market.

Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British Columbia's status as a global hub for health innovation.

Central Garden & Pet's latest launch isn't just a cat treat; it's a calculated move into the underserved, high-growth feline calming market. Here's the strategy.

Gelteq aims to replace needles with its ingestible gel, targeting diabetes and more. But can it balance this lofty goal with near-term revenue and tight finances?

A new survey reveals the deep toll of canine skin allergies on pets and owners, exposing a massive unmet need that has pharmaceutical giants racing for a cure.

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

Startup Crumb just won a major tech award for its pet safety platform. Its secret? An AI that scans your dog's nose print, creating an unforgeable ID.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

A breakthrough publication identifies a novel protein, LanCL1, as a key target for neuropathic pain, validating a new class of drugs for millions of sufferers.

Sanofi's latest FDA nod for Tzield isn't just a new drug approval; it's a strategic shift from symptom management to disease modification in Type 1 Diabetes.

Australian biotech Gelteq has a gel that makes bitter medicine taste good to dogs. It's more than a pet owner's dream—it's a strategic move in a $47B market.

New data reveals a shocking AI divide. Mars Petcare brands dominate AI search, while 80% of independent vets have become digitally invisible to pet owners.

A new book signals a major shift in the veterinary industry, where AI-driven strategy is becoming the key to survival and growth in a competitive market.